VibraQ

VibraQ is a medical technology company developing a rapid, point-of-care diagnostic platform for the detection of infectious diseases. The company's core technology combines surface-enhanced Raman spectroscopy (SERS) with proprietary artificial intelligence algorithms to identify pathogens from biological samples in minutes. This non-invasive approach aims to provide lab-quality results without the need for complex sample preparation or specialized laboratory infrastructure. Initially focused on respiratory viruses like SARS-CoV-2 and influenza, VibraQ's platform is designed to be scalable for a wide range of clinical and environmental diagnostic applications.